Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fragrance Foundation chairman

This article was originally published in The Rose Sheet

Executive Summary

Estee Lauder Group President Patrick Bousquet-Chavanne tapped as chairman to fill remaining one-year term of chairman emeritus and fellow Lauder exec Philip Shearer. Estee Lauder International Group President Shearer resigned from the post Nov. 12 after serving two years. Bousquet-Chavanne also was elected to serve on the board for three-year term, foundation says. Foundation appoints new exec committee to serve with Bousquet-Chavanne, including Liz Claiborne Cosmetics President Neil Katz, Parfums Givenchy President and CEO Camille McDonald, Coty Beauty Americas President Eric Thoreux, Quest International President Damas Thoman and Fragrance Foundation President Annette Green...

You may also be interested in...

Interview: Double Delight For ImmuPharma's Dimitriou

It has been a long and sometimes tortuous development path for Lupuzor but ImmuPharma's chief executive tells Scrip the company's faith in the lupus drug is bearing fruit.

Patient Voice Makes Impact In Scientific Advice From EU HTA Network

The EU network of health technology assessment bodies says it is seeing the benefit of systematically involving patients when companies approach it for early scientific advice on evidence generation.

MSF Wants Faster Deployment Of Ebola Vaccine At ‘Fair’ Price

As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks. 




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts